· Weekly signal · MRNA
Moderna Inc (MRNA) weekly reversal tests a biotech rebound
The pullback matters because longer weekly returns remain positive, leaving the setup supported but no longer one-way.
Moderna Inc (MRNA) fell 14.4% in the week ended July 10, closing at 68.27 USD. The drop cut into a recent advance but did not erase the stock’s 36.8% four-week gain or its 27.1% twelve-week rise.
The confirming evidence is mixed. The weekly trend signal remains active and Market Dynamics shows modest confirmation, while Relative Strength sits near neutral at 49.3. The weekly price path over 52 weeks frames the move as a setback within a broader rebound rather than live intraday action.